MedPath

CLOPIXOL ACUPHASE - LIQ IM 50MG/ML

CLOPIXOL ACUPHASE - LIQ IM 50MG/ML

Discontinued
DIN Number

02162946

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

hoechst marion roussel canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02162946
AIG Number0127601001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AF05 ZUCLOPENTHIXOL
Product Specifications
Dosage FormLiquid
Route of AdministrationIntramuscular
AHFS Classification28:16.08.32
Health Canada Classification

ACTIVE INGREDIENTS (1)

ZUCLOPENTHIXOL ACETATEActive
Strength: 50 MG / ML
Monograph: ZUCLOPENTHIXOL ACETATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.